New treatment study for children with Tourette syndrome

We are now enrolling children with TS, ages 6-17, in a new treatment study. The research study will compare an investigational product, EBS-101 a.k.a. ecopipam, to a placebo (inactive substance).¬†Further information about the study is available at this site, where you can complete a pre-screening questionnaire, or at ClinicalTrials.gov. If you have questions, or to […]